BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dong WG, Sun XM, Yu BP, Luo HS, Yu JP. Role of VEGF and CD44v6 in differentiating benign from malignant ascites. World J Gastroenterol 2003; 9(11): 2596-2600 [PMID: 14606105 DOI: 10.3748/wjg.v9.i11.2596]
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2596.htm
Number Citing Articles
Solange Maria Diniz Bizzo, Débora Dummer Meira, José Marinaldo Lima, Jânio da Silva Mororó, José Cláudio Casali-da-Rocha, Maria Helena Faria Ornellas. Peritoneal VEGF burden as a predictor of cytoreductive surgery outcome in women with epithelial ovarian cancerInternational Journal of Gynecology & Obstetrics 2010; 109(2): 113 doi: 10.1016/j.ijgo.2009.11.021
Konstantinos Karatolios, Sabine Pankuweit, Rainer Georg Moosdorf, Bernhard Maisch. Vascular Endothelial Growth Factor in Malignant and Benign Pericardial EffusionClinical Cardiology 2012; 35(6): 377 doi: 10.1002/clc.21967
Amene Saghazadeh, Nima Rezaei, Martin E. Rottenberg. Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysisPLOS ONE 2022; 17(5): e0268543 doi: 10.1371/journal.pone.0268543
Akihiro Sako, Joji Kitayama, Dai Shida, Rika Suzuki, Teruyuki Sakai, Hideo Ohta, Hirokazu Nagawa. Lysophosphatidic Acid (LPA)-Induced Vascular Endothelial Growth Factor (VEGF) by Mesothelial Cells and Quantification of Host-Derived VEGF in Malignant AscitesJournal of Surgical Research 2006; 130(1): 94 doi: 10.1016/j.jss.2005.08.007
Solange Maria Diniz Bizzo, Débora Dummer Meira, José Marinaldo Lima, Jânio da Silva Mororó, Fábio Carvalho de Barros Moreira, José Cláudio Casali-da-Rocha, Maria Helena Faria Ornellas. Serum albumin and vascular endothelial growth factor in epithelial ovarian cancer: looking at adnexal tumor drainageArchives of Gynecology and Obstetrics 2011; 283(4): 855 doi: 10.1007/s00404-010-1491-4
Bogdan Zalewski. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical featuresWorld Journal of Gastroenterology 2004; 10(4): 583-585 doi: 10.3748/wjg.v10.i4.583
Feilim Mac Gabhann, Aleksander S. Popel. Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscleAmerican Journal of Physiology-Heart and Circulatory Physiology 2007; 292(1): H459 doi: 10.1152/ajpheart.00637.2006
Jing Wang, Qin-shu Kang, Xiao-guang Lv, Jia Song, Na Zhan, Wei-guo Dong, Wei-hua Huang, Yuan-Soon Ho. Simple Patterned Nanofiber Scaffolds and Its Enhanced Performance in ImmunoassayPLoS ONE 2013; 8(12): e82888 doi: 10.1371/journal.pone.0082888
Samar Masoumi Moghaddam, Afshin Amini, David L. Morris, Mohammad H. Pourgholami. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancerCancer and Metastasis Reviews 2012; 31(1-2): 143 doi: 10.1007/s10555-011-9337-5
Saeed Zarei, Ali Ahmad Bayat, Reza Hadavi, Ahmad R. Mahmoudi, Banafsheh Tavangar, Yasaman Vojgani, Mahmood Jeddi-Tehrani, Zahra Amirghofran. Production and Characterization of a Peptide-based Monoclonal Antibody Against CD44 Variant 6Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2015; 34(1): 36 doi: 10.1089/mab.2014.0077
Sylvia Stadlmann, Albert Amberger, Juergen Pollheimer, Guenther Gastl, Felix Albert Offner, Raimund Margreiter, Alain Gustave Zeimet. Ovarian carcinoma cells and IL-1β-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusionsGynecologic Oncology 2005; 97(3): 784 doi: 10.1016/j.ygyno.2005.02.017
Ben Davidson. Serous Effusions2018; : 283 doi: 10.1007/978-3-319-76478-8_12
Ben Davidson. Serous Effusions2012; : 241 doi: 10.1007/978-0-85729-697-9_12
Ben Davidson. Serous Effusions2018; : 191 doi: 10.1007/978-3-319-76478-8_9
Sebastian Kobold, Susanna Hegewisch-Becker, Karin Oechsle, Karin Jordan, Carsten Bokemeyer, Djordje Atanackovic. Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?The Oncologist 2009; 14(12): 1242 doi: 10.1634/theoncologist.2009-0109
Hao Jiang, Wei Zhao, Wei Shao. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysisTumor Biology 2014; 35(8): 7383 doi: 10.1007/s13277-014-2150-3
Xiaoping Wang, Qiaoxia Wang, Huanping Lin, Sanzhong Li, Lijun Sun, Yixin Yang. HSP72 and gp96 in gastroenterological cancersClinica Chimica Acta 2013; 417: 73 doi: 10.1016/j.cca.2012.12.017
Ahmed Abdel-Razik, Nasser Mousa, Hatem Elalfy, Tarek Fouad Sheta, Mahmoud Awad, Mostafa Abdelsalam, Rania Elhelaly, Rasha Elzehery, Nawal S. Gouda, Waleed Eldars. A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of AscitesJournal of Gastrointestinal Cancer 2017; 48(1): 50 doi: 10.1007/s12029-016-9873-x
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2005; : 91 doi: 10.1007/3-540-27194-5_8
Na Zhan, Wei-Guo Dong, Jing Wang. The clinical significance of vascular endothelial growth factor in malignant ascitesTumor Biology 2016; 37(3): 3719 doi: 10.1007/s13277-015-4198-0
Xiaoping Wang, Huanping Lin, Qiaoxia Wang, Jiqing Bai, Xiaoping Ying, Lansheng Guo, Yanhong Zhao, Yan Fang. Interaction between Heat Shock Protein 72 and CD44v6 in Human Colonic adenocarcinoma2010 4th International Conference on Bioinformatics and Biomedical Engineering 2010; : 1 doi: 10.1109/ICBBE.2010.5516371
I. NASCIMENTO, R. SCHAER, D. LEMAIRE, S. FREIRE, B. PAULE, S. CARVALHO, R. MEYER, H. SCHAER-BARBOSA. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascitesAPMIS 2004; 112(9): 585 doi: 10.1111/j.1600-0463.2004.apm1120904.x
Hae Kyung Lee, Hiun Suk Chae, Jin Soo Kim, Hyung Keun Kim, Young Seok Cho, Sang Young Rho, Jin-Hyoung Kang, Seok Goo Cho, Hong Seok Jang, Kyungja Han. Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patientsYonsei Medical Journal 2008; 49(3): 429 doi: 10.3349/ymj.2008.49.3.429
Meike Körner, Beatrice Waser, Jean Claude Reubi, Laurence J. Miller. CCK2 receptor splice variant with intron 4 retention in human gastrointestinal and lung tumoursJournal of Cellular and Molecular Medicine 2010; 14(4): 933 doi: 10.1111/j.1582-4934.2009.00859.x
Ben Davidson. Serous Effusions2012; : 167 doi: 10.1007/978-0-85729-697-9_9
Katarina Galic Jerman, Borut Kobal, Marina Jakimovska, Ivan Verdenik, Katarina Cerne. Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopyWorld Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-278
Dongrong Situ, Hao Long, Peng Lin, Zhihua Zhu, Jiang Wang, Xu Zhang, Zeming Xie, Tiehua Rong. Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinomaJournal of Cancer Research and Clinical Oncology 2010; 136(8): 1213 doi: 10.1007/s00432-010-0771-5
Xiaoping Wang, Huanping Lin, Qiaoxia Wang, Jiqing Bai, Xiaoping Ying. Co-localization of heat shock protein 72 and CD44v6 in human colonic adenocarcinoma2010 3rd International Conference on Biomedical Engineering and Informatics 2010; : 2467 doi: 10.1109/BMEI.2010.5639790
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2010; : 421 doi: 10.1007/978-3-642-00150-5_28